Zions Bancorporation, N.A. Abb Vie Inc. Transaction History

Zions Bancorporation, N.A.

$1.24 Billion
Q2 2024

A detailed history of Zions Bancorporation, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 28,859 shares of ABBV stock, worth $5.68 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

28,859

Previous 32,837 12.11%

Holding current value

$5.68 Million

Previous $5.98 Million 17.23%

% of portfolio

0.4%

Previous 0.44%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $615,754 - $719,063	-3,978 Reduced 12.11%	28,859 $4.95 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $2.98 Million - $3.4 Million	-18,667 Reduced 36.24%	32,837 $5.98 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $1.01 Million - $1.14 Million	7,338 Added 16.61%	51,504 $7.98 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $337,849 - $391,109	2,529 Added 6.07%	44,166 $6.58 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $982,959 - $1.22 Million	-7,418 Reduced 15.12%	41,637 $5.61 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $1 Million - $1.15 Million	6,921 Added 16.43%	49,055 $7.82 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $467,349 - $560,474	3,379 Added 8.72%	42,134 $6.81 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $406,253 - $465,946	-3,027 Reduced 7.24%	38,755 $5.2 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $1.91 Million - $2.43 Million	-13,872 Reduced 24.93%	41,782 $6.4 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $760,600 - $943,691	5,763 Added 11.55%	55,654 $9.02 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $341,197 - $431,713	3,176 Added 6.8%	49,891 $6.76 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $67,670 - $76,816	636 Added 1.38%	46,715 $5.04 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $729,420 - $812,616	6,933 Added 17.71%	46,079 $5.19 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $787,812 - $867,286	7,701 Added 24.49%	39,146 $4.24 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $35,496 - $47,923	-441 Reduced 1.38%	31,445 $3.37 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $296,475 - $347,964	-3,451 Reduced 9.77%	31,886 $2.79 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $144,318 - $193,120	-1,967 Reduced 5.27%	35,337 $3.47 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $362,038 - $548,895	5,613 Added 17.71%	37,304 $2.84 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $274,094 - $342,950	-3,800 Reduced 10.71%	31,691 $2.81 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $238,568 - $286,827	3,788 Added 11.95%	35,491 $2.69 Million
Q2 2019 Jul 09, 2019	BUY	$65.7 - $83.98 $189,807 - $242,618	2,889 Added 10.03%	31,703 $2.31 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $153,894 - $181,126	1,995 Added 7.44%	28,814 $2.32 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $2.09 Million - $2.57 Million	26,819 New	26,819 $2.47 Million

Others Institutions Holding ABBV

# of Institutions

3,696

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Abb Vie Inc. Transaction History